PATH | VRL
Menu

Respiratory Syncytial Virus Vaccine Development

Despite half a century of dedicated research, there remains no licensed vaccine product against respiratory syncytial virus (RSV). This article, published in Expert Review of Vaccines, describes efforts to harness innate and adaptive immune potentials to combat RSV. The author reviews a plethora of candidate vaccine products and strategies, and concludes that the development of a successful RSV vaccine may ultimately stem from attention to historical lessons, in concert with an integral partnering of immunology and virology research fields. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author: Hurwitz JL

Published: 2011

» Visit web page (English)

(Located at www.expert-reviews.com)

Citation: Hurwitz JL. Respiratory Syncytial Virus Vaccine Development. Expert Review of Vaccines. 2011;10(10):1415-1433.

Resource types: Peer-reviewed journal

Diseases/vaccines: Respiratory syncytial virus (RSV)

Topics: Disease/vaccine specific information

Regions: Global